Simultaneous analytical method [Bioanalytics]

posted by Obinoscopy  – USA, 2018-09-12 09:35 (805 d 03:46 ago) – Posting: # 19268
Views: 2,466

Dear Giang

» It's a bioanalytical method for determination of 5 anti-TB drugs by LC-MS/MS. One just raise the question: Can we apply this method for just 2/3 APIs? Is there any infuence or differences? Do we need to revalidate the method, partial or full, and which criteria? Many thanks!

I don't think you need to revalidate as long as the 2/3 APIs were among the 5 APIs that were validated.

But if I may ask, did you include all the CCs and QCs for the entire 5 APIs in the same analytical run?

Scopy

Complete thread:

Activity
 Admin contact
21,209 posts in 4,426 threads, 1,481 registered users;
online 16 (0 registered, 16 guests [including 7 identified bots]).
Forum time: Wednesday 12:22 CET (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5